Concepedia

Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children

Michael E. Pichichero, Janet R. Casey, Mark M. Blatter, Edward Rothstein, Robert Ryall, Mike Bybel, Gregory Gilmet, Thomas Papa

The Pediatric Infectious Disease Journal · 2005 · 120 citations · 10 references

DOI

Abstract

In 2- to 10-year-old children MCV-4 had a safety profile similar to that of PSV-4 and elicited significantly higher and more persistent serum bactericidal antibody responses against meningococcal serogroups A, C, Y and W-135 than did the licensed polysaccharide vaccine.

References

10

Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

PEDIATRICS · 2013 · 1.8K citations · Full text

, , +22

Bacterial Meningitis in the United States in 1995

Anne Schuchat, Katherine A. Robinson, Jay D. Wenger et al. · New England Journal of Medicine · 1997 · 1.3K citations

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

Elizabeth Miller, David Salisbury, Mary Ramsay · Vaccine · 2001 · 477 citations

, , +7

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

Nancy E. Rosenstein, Bradley A. Perkins, David S. Stephens et al. · The Journal of Infectious Diseases · 1999 · 448 citations

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

Malcolm S. Artenstein, Ronald Gold, James G. Zimmerly et al. · New England Journal of Medicine · 1970 · 371 citations

, , +14